Ying Chen
Xuzhou Medical College
20 Papers
8 Citations
Ying Chen is an academic researcher from Xuzhou Medical College. The author has contributed to research in topics: Shigella & Shigella flexneri. The author has an hindex of 7, co-authored 19 publications.
Chat about Author
Papers
Application of MALDI-TOF MS to rapid identification of anaerobic bacteria
Ying Li,Mingzhu Shan,Zuobin Zhu,Xuhua Mao,Mingju Yan,Ying Chen,Qiuju Zhu,Hongchun Li,Bing Gu +8 more
TL;DR: This research showed that MALDI-TOF-MS was satisfactory in genus identification of clinical pathogenic anaerobic bacteria, however, this method still suffers from different drawbacks in precise identification of rare anaerobe and species levels of common an aerobic bacteria.
Recent advances in rapid pathogen detection method based on biosensors
TL;DR: The main goal of this contribution is to discuss critically the development and application of many kinds of biosensors such as electrochemical (amperometric, impedimetric, potentiometric, and conductometric), optical (fluorescent, fibre optic and surface plasmon resonance), and piezoelectric (quartz crystal microbalances and atomic force microscopy) biosensor in pathogen detection as well as the comparisons with the existing clinical detection methods.
59
Evaluation of neurosurgical implant infection rates and associated pathogens: evidence from 1118 postoperative infections
TL;DR: The total IR was high in neurosurgical implants and should be taken seriously, and the main pathogen in neurosurgery was S. aureus, which can provide a certain reference for the clinic.
Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum.
Hui Li,Zhenzhen Wang,Zhenzhen Wang,Guodong Zhao,Yong Ma,Ying Chen,Qi Xue,Minxue Zheng,Sujuan Fei +8 more
TL;DR: Secreted frizzled-related protein 2 (SFRP2) has been found to be hypermethylated in most colorectal cancer patients, and it may fulfill the role of a non-invasive biomarker for coloreCTal cancer screening.
37
Teasaponin Ameliorates Murine Colitis by Regulating Gut Microbiota and Suppressing the Immune System Response.
TL;DR: It is demonstrated that TS ameliorated murine colitis through the modulation of immune response, mucus barrier and gut microbiota, thus improving gut dysbiosis and providing a promising perspective on the clinical treatment of IBD.